☰

Brian J. Budke, Ph.D. - Publications

Affiliations: 
2009 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Area:
Microbiology Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Budke B, Zhong A, Sullivan K, Park C, Gittin DI, Kountz TS, Connell PP. Noncanonical NF-κB factor p100/p52 regulates homologous recombination and modulates sensitivity to DNA-damaging therapy. Nucleic Acids Research. PMID 35689636 DOI: 10.1093/nar/gkac491  0.455
2019 Budke B, Tueckmantel W, Miles K, Kozikowski AP, Connell PP. Optimization of Drug Candidates that Inhibit the D-loop Activity of RAD51. Chemmedchem. PMID 30957434 DOI: 10.1002/Cmdc.201900075  0.499
2019 Chlenski A, Park C, Dobratic M, Salwen HR, Budke B, Park JH, Miller R, Applebaum MA, Wilkinson E, Nakamura Y, Connell PP, Cohn SL. Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma. Molecular Cancer Therapeutics. PMID 30674566 DOI: 10.1158/1535-7163.Mct-18-0819  0.452
2017 Budke B, Lv W, Tueckmantel W, Kozikowski A, Connell P. Abstract PR02: Small molecules that specifically inhibit the D-loop activity of RAD51 Molecular Cancer Research. 15. DOI: 10.1158/1557-3125.Dnarepair16-Pr02  0.568
2016 Budke B, Lv W, Kozikowski AP, Connell PP. Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy? Chemmedchem. PMID 27781374 DOI: 10.1002/Cmdc.201600426  0.54
2016 Lv W, Budke B, Pawlowski M, Connell PP, Kozikowski AP. Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51. Journal of Medicinal Chemistry. PMID 27049177 DOI: 10.1016/J.Ijrobp.2016.06.053  0.437
2015 Thierry S, Benleulmi MS, Sinzelle L, Thierry E, Calmels C, Chaignepain S, Waffo-Teguo P, Merillon JM, Budke B, Pasquet JM, Litvak S, Ciuffi A, Sung P, Connell P, Hauber I, et al. Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration. Chemistry & Biology. 22: 712-23. PMID 26051216 DOI: 10.1016/J.Chembiol.2015.04.020  0.321
2015 Mason JM, Dusad K, Wright WD, Grubb J, Budke B, Heyer WD, Connell PP, Weichselbaum RR, Bishop DK. RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells. Nucleic Acids Research. 43: 3180-96. PMID 25765654 DOI: 10.1093/Nar/Gkv175  0.516
2014 Mason JM, Logan HL, Budke B, Wu M, Pawlowski M, Weichselbaum RR, Kozikowski AP, Bishop DK, Connell PP. The rad51-stimulatory compound rs-1 can exploit the rad51 overexpression that exists in cancer cells and tumors Cancer Research. 74: 3546-3555. PMID 24753542 DOI: 10.1158/0008-5472.Can-13-3220  0.503
2014 Pitroda SP, Pashtan IM, Logan HL, Budke B, Darga TE, Weichselbaum RR, Connell PP. DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy. Science Translational Medicine. 6: 229ra42. PMID 24670686 DOI: 10.1126/Scitranslmed.3008291  0.529
2013 Budke B, Chan YL, Bishop DK, Connell PP. Real-time solution measurement of RAD51- and RecA-mediated strand assimilation without background annealing. Nucleic Acids Research. 41: e130. PMID 23666628 DOI: 10.1093/Nar/Gkt362  0.495
2013 Budke B, Kalin JH, Pawlowski M, Zelivianskaia AS, Wu M, Kozikowski AP, Connell PP. An optimized RAD51 inhibitor that disrupts homologous recombination without requiring michael acceptor reactivity Journal of Medicinal Chemistry. 56: 254-263. PMID 23231413 DOI: 10.1021/Jm301565B  0.462
2012 Cloud V, Chan YL, Grubb J, Budke B, Bishop DK. Rad51 is an accessory factor for Dmc1-mediated joint molecule formation during meiosis. Science (New York, N.Y.). 337: 1222-5. PMID 22955832 DOI: 10.1126/Science.1219379  0.44
2012 Budke B, Logan HL, Kalin JH, Zelivianskaia AS, Cameron McGuire W, Miller LL, Stark JM, Kozikowski AP, Bishop DK, Connell PP. RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Research. 40: 7347-57. PMID 22573178 DOI: 10.1093/Nar/Gks353  0.578
2010 Budke B, Kuzminov A. Production of clastogenic DNA precursors by the nucleotide metabolism in Escherichia coli. Molecular Microbiology. 75: 230-45. PMID 19943897 DOI: 10.1111/J.1365-2958.2009.06994.X  0.527
2006 Budke B, Kuzminov A. Hypoxanthine incorporation is nonmutagenic in Escherichia coli. Journal of Bacteriology. 188: 6553-60. PMID 16952947 DOI: 10.1128/Jb.00447-06  0.489
Show low-probability matches.